Net Loss Per Share (Tables)

3 Months Ended

Mar. 31, 2023

Schedule of basic and diluted net loss per share

Basic and diluted net loss per share attributable to common shareholders of Biohaven was calculated as follows:


	Three Months Ended March 31,
	2023		2022
Numerator:

Net loss	$	(70,492)	$	(97,032)
Denominator:
Weighted average common shares outstanding—basic and diluted(1)	68,206,879		39,375,944
Net loss per share — basic and diluted	$	(1.03)	$	(2.46)

(1) Prior to the Spin-Off from the Former Parent on October 3, 2022, Biohaven did not operate as an independent company. At the time of the Distribution, 39,375,944 shares of the Company's common stock were distributed to the Former Parent's shareholders, including common shares issued in connection with Former Parent share options that were exercised on October 3, 2022 and common shares issued in connection with Former Parent restricted share units that vested on October 3, 2022. This number of shares is being utilized for the calculation of basic and diluted earnings per share for all periods presented prior to the Spin-Off.

Schedule of potentially anti-dilutive securities excluded from calculation of diluted net loss per share

The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to common shareholders for the periods indicated because including them would have had an anti-dilutive effect:


						As of March 31,
						2023
Options to purchase common shares						9,083,715